Ionis Pharmaceuticals, Inc. Depreciation
Ionis Pharmaceuticals, Inc. (IONS) reported Depreciation of $6.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. depreciation for the quarter ending 2026-06-30 was $3.43M, a 51.50% increase year-over-year.
- Ionis Pharmaceuticals, Inc. depreciation for the quarter ending 2026-03-31 was $3.30M, a 48.16% increase year-over-year.
- Ionis Pharmaceuticals, Inc. depreciation for the quarter ending 2025-12-31 was $3.26M, a 45.49% increase year-over-year.
- Ionis Pharmaceuticals, Inc. depreciation for the quarter ending 2025-09-30 was $2.25M, a 4.49% decline year-over-year.
- Ionis Pharmaceuticals, Inc. depreciation for fiscal 2025 was $10.01M, a 4.10% increase from fiscal 2024.
- Ionis Pharmaceuticals, Inc. depreciation for fiscal 2024 was $9.61M, a 6.59% decline from fiscal 2023.
- Ionis Pharmaceuticals, Inc. depreciation for fiscal 2023 was $10.29M, a 28.17% decline from fiscal 2022.
- Ionis Pharmaceuticals, Inc. depreciation for fiscal 2022 was $14.33M, a 7.48% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $6.73M 10-Q · filed 2026-07-29 | $9.99M derived: sum of 3 quarters · filed 2026-07-29 | $12.25M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $3.30M 10-Q · filed 2026-04-29 | $6.56M derived: sum of 2 quarters · filed 2026-04-29 | $8.81M derived: sum of 3 quarters · filed 2026-04-29 | $11.08M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.51M derived: sum of 2 quarters · filed 2026-02-26 | $7.78M derived: sum of 3 quarters · filed 2026-07-29 | $10.01M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $4.52M derived: sum of 2 quarters · filed 2026-07-29 | $6.75M 10-Q · filed 2025-10-29 | $8.99M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $4.49M 10-Q · filed 2026-07-29 | $6.73M derived: sum of 3 quarters · filed 2026-07-29 | $9.10M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $2.23M 10-Q · filed 2026-04-29 | $4.47M derived: sum of 2 quarters · filed 2026-04-29 | $6.83M derived: sum of 3 quarters · filed 2026-04-29 | $9.29M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.60M derived: sum of 2 quarters · filed 2026-02-26 | $7.07M derived: sum of 3 quarters · filed 2026-02-26 | $9.61M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $4.83M derived: sum of 2 quarters · filed 2025-10-29 | $7.37M 10-Q · filed 2025-10-29 | $9.92M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $5.01M 10-Q · filed 2025-07-30 | $7.56M derived: sum of 3 quarters · filed 2026-02-26 | $10.08M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.55M 10-Q · filed 2025-04-30 | $5.09M derived: sum of 2 quarters · filed 2026-02-26 | $7.61M derived: sum of 3 quarters · filed 2026-02-26 | $10.23M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.07M derived: sum of 2 quarters · filed 2026-02-26 | $7.69M derived: sum of 3 quarters · filed 2026-02-26 | $10.29M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $5.14M derived: sum of 2 quarters · filed 2024-11-06 | $7.75M 10-Q · filed 2024-11-06 | $10.78M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.22M 10-Q · filed 2024-08-01 | $8.25M derived: sum of 3 quarters · filed 2025-02-19 | $12.07M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $2.60M 10-Q · filed 2024-05-07 | $5.63M derived: sum of 2 quarters · filed 2025-02-19 | $9.45M derived: sum of 3 quarters · filed 2025-02-19 | $13.23M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $6.84M derived: sum of 2 quarters · filed 2025-02-19 | $10.63M derived: sum of 3 quarters · filed 2025-02-19 | $14.33M 10-K · filed 2025-02-19 |
| 2022-09-30 | $3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $7.60M derived: sum of 2 quarters · filed 2023-11-02 | $11.30M 10-Q · filed 2023-11-02 | $15.12M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $3.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $7.48M 10-Q · filed 2023-08-09 | $11.31M derived: sum of 3 quarters · filed 2024-02-21 | $15.02M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $3.70M 10-Q · filed 2023-05-03 | $7.52M derived: sum of 2 quarters · filed 2024-02-21 | $11.24M derived: sum of 3 quarters · filed 2024-02-21 | $15.27M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $7.54M derived: sum of 2 quarters · filed 2024-02-21 | $11.57M derived: sum of 3 quarters · filed 2024-02-21 | $15.49M 10-K · filed 2024-02-21 |
| 2021-09-30 | $3.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $7.75M derived: sum of 2 quarters · filed 2022-11-09 | $11.66M 10-Q · filed 2022-11-09 | $15.32M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $4.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $7.95M 10-Q · filed 2022-08-09 | $11.60M derived: sum of 3 quarters · filed 2023-02-22 | $14.96M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $3.92M 10-Q · filed 2022-05-04 | $7.57M derived: sum of 2 quarters · filed 2023-02-22 | $10.92M derived: sum of 3 quarters · filed 2023-02-22 | $14.05M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $7.00M derived: sum of 2 quarters · filed 2023-02-22 | $10.13M derived: sum of 3 quarters · filed 2023-02-22 | $13.37M 10-K · filed 2023-02-22 |
| 2020-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $6.48M derived: sum of 2 quarters · filed 2021-11-03 | $9.71M 10-Q · filed 2021-11-03 | $12.91M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $3.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $6.36M 10-Q · filed 2021-08-04 | $9.55M derived: sum of 3 quarters · filed 2022-02-25 | $12.65M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $3.23M 10-Q · filed 2021-05-05 | $6.43M derived: sum of 2 quarters · filed 2022-02-25 | $9.52M derived: sum of 3 quarters · filed 2022-02-25 | $12.70M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $6.29M derived: sum of 2 quarters · filed 2022-02-25 | $9.47M derived: sum of 3 quarters · filed 2022-02-25 | $12.54M 10-K · filed 2022-02-25 |
| 2019-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $6.27M derived: sum of 2 quarters · filed 2020-11-04 | $9.35M 10-Q · filed 2020-11-04 | $12.40M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $6.25M 10-Q · filed 2020-08-05 | $9.31M derived: sum of 3 quarters · filed 2021-02-24 | $12.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $3.07M 10-Q · filed 2020-05-06 | $6.13M derived: sum of 2 quarters · filed 2021-02-24 | $8.92M derived: sum of 3 quarters · filed 2021-02-24 | $11.42M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $5.85M derived: sum of 2 quarters · filed 2021-02-24 | $8.34M derived: sum of 3 quarters · filed 2021-02-24 | $10.71M 10-K · filed 2021-02-24 |
| 2018-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $5.29M derived: sum of 2 quarters · filed 2019-11-06 | $7.65M 10-Q · filed 2019-11-06 | $8.22M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $4.86M 10-Q · filed 2019-08-08 | $5.43M derived: sum of 3 quarters · filed 2020-03-02 | $7.58M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $2.36M 10-Q · filed 2019-05-09 | $2.93M derived: sum of 2 quarters · filed 2020-03-02 | $5.08M derived: sum of 3 quarters · filed 2020-03-02 | $7.09M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $570.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.72M derived: sum of 2 quarters · filed 2020-03-02 | $4.73M derived: sum of 3 quarters · filed 2020-03-02 | $6.71M 10-K · filed 2020-03-02 |
| 2017-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $4.16M derived: sum of 2 quarters · filed 2018-11-06 | $6.14M 10-Q · filed 2018-11-06 | $8.03M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.99M 10-Q · filed 2018-08-07 | $5.88M derived: sum of 3 quarters · filed 2019-03-01 | $7.76M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $1.98M 10-Q · filed 2018-05-07 | $3.87M derived: sum of 2 quarters · filed 2019-03-01 | $5.75M derived: sum of 3 quarters · filed 2019-03-01 | $7.62M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $3.77M derived: sum of 2 quarters · filed 2019-03-01 | $5.64M derived: sum of 3 quarters · filed 2019-03-01 | $7.48M 10-K · filed 2019-03-01 |
| 2016-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.75M derived: sum of 2 quarters · filed 2017-11-07 | $5.59M 10-Q · filed 2017-11-07 | $7.39M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.71M 10-Q · filed 2017-08-09 | $5.51M derived: sum of 3 quarters · filed 2018-02-28 | $7.29M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $1.84M 10-Q · filed 2017-05-09 | $3.63M derived: sum of 2 quarters · filed 2018-02-28 | $5.42M derived: sum of 3 quarters · filed 2018-02-28 | $7.25M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.58M derived: sum of 2 quarters · filed 2018-02-28 | $5.41M derived: sum of 3 quarters · filed 2018-02-28 | $6.98M 10-K · filed 2018-02-28 |
| 2015-09-30 | $1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $3.62M derived: sum of 2 quarters · filed 2016-11-09 | $5.19M 10-Q · filed 2016-11-09 | $6.78M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.41M 10-Q · filed 2016-08-09 | $5.00M derived: sum of 3 quarters · filed 2017-03-01 | $6.64M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $1.57M 10-Q · filed 2016-05-05 | $3.16M derived: sum of 2 quarters · filed 2017-03-01 | $4.81M derived: sum of 3 quarters · filed 2017-03-01 | $6.39M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.24M derived: sum of 2 quarters · filed 2017-03-01 | $4.82M derived: sum of 3 quarters · filed 2017-03-01 | $6.38M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.23M derived: sum of 2 quarters · filed 2015-11-09 | $4.79M 10-Q · filed 2015-11-09 | $6.39M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.14M 10-Q · filed 2015-08-05 | $4.74M derived: sum of 3 quarters · filed 2016-02-26 | $6.36M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $1.56M 10-Q · filed 2015-05-05 | $3.16M derived: sum of 2 quarters · filed 2016-02-26 | $4.78M derived: sum of 3 quarters · filed 2016-02-26 | $6.45M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $3.22M derived: sum of 2 quarters · filed 2016-02-26 | $4.88M derived: sum of 3 quarters · filed 2016-02-26 | $6.59M 10-K · filed 2016-02-26 |
| 2013-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $3.29M derived: sum of 2 quarters · filed 2014-11-07 | $5.00M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $3.38M 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | $1.71M 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | $7.07M 10-K · filed 2015-03-02 | |||
| 2011-12-31 | $6.59M 10-K · filed 2014-03-03 | |||
| 2010-12-31 | $4.84M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $3.94M 10-K · filed 2012-02-29 | |||
| 2008-12-31 | $2.87M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |